Page 3 - Research Row News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research row. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Row Today - Breaking & Trending Today

Edgewise Therapeutics Announces Positive 12-Month Topline Results from the ARCH Open Label Study of EDG-5506 in Adults with Becker Muscular Dystrophy (BMD)

– Sustained positive trend in North Star Ambulatory Assessment (NSAA) scores relative to BMD natural history –

– Significant decreases in levels of serum creatine kinase (CK) and fast skeletal muscle troponin I (TNNI2), enzyme biomarkers associated with skeletal muscle damage–

– EDG-5506 was well-tolerated at all doses –

– Company continuing to enroll patients with BMD in the CANYON Phase 2 trial which now includes a pivotal cohort called GRAND CANYON –

– Edgewise leadership to discuss ARCH findings on Tuesday, June 27 at 8:30 a.m. Eastern Time at virtual investor event – ....

United States , United Kingdom , Joanne Donovan , Craig Mcdonald , University Of California Davis , Department Of Physical Medicine Rehabilitation , Drug Administration , Edgewise Therapeutics Inc , Exchange Commission , Securities Exchange , Research Row , Edgewise Therapeutics , Therapeutics Figure , Business Wire , Chief Medical Officer , Physical Medicine , Review Virtual Investor , Therapeutics Presentations , Parent Project Muscular Dystrophy , Therapeutic Chief Medical Officer , Impacting Downstream , Fast Track , Limb Girdle , Functional Changes , Becker Muscular Dystrophy , Clinical Trials ,